Delirium and IL-6 added to clinical scores improves their performance: a prospective analysis of CALL, PREDI-CO, MRS score applied to a population of patients admitted to internal medicine ward.
CALL
Covid-19
Delirium,il-6
MRS
Outcome
PREDI-CO
Score
Journal
Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
05
02
2023
accepted:
01
06
2023
medline:
18
9
2023
pubmed:
17
6
2023
entrez:
17
6
2023
Statut:
ppublish
Résumé
This study aimed to evaluate the effectiveness of various scoring systems in predicting in-hospital mortality for COVID-19 patients admitted to the internal medicine ward. We conducted a prospective collection of clinical data from patients admitted to the Internal Medicine Unit at Santa Maria Nuova Hospital in Florence, Italy, with confirmed pneumonia caused by SARS-CoV-2. We calculated three scoring systems: the CALL score, the PREDI-CO score, and the COVID-19 in-hospital Mortality Risk Score (COVID-19 MRS). The primary endpoint was in-hospital mortality. : A total of 681 patients were enrolled in the study, with a mean age of 68.8 ± 16.1 years, and 54.8% of them were male. Non-survivors had significantly higher scores in all prognostic systems compared to survivors (MRS: 13 [12- 15] vs. 10 [8-12]; CALL: 12 [10-12] vs. 9 [7-11]; PREDI-CO: 4 [3-6] vs. 2 [1-4]; all p<0.001). The receiver operating characteristic (ROC) analysis yielded the following area under the curve (AUC) values: MRS 0.85, CALL 0.78, PREDI-CO 0.77. The addition of Delirium and IL6 to the scoring systems improved their discriminative ability, resulting in AUC values of 0.92 for MRS, 0.87 for CALL, and 0.84 for PREDI-CO. The mortality rate increased significantly across increasing quartiles (p<0.001). In conclusion the COVID-19 in-hospital Mortality Risk Score (MRS) demonstrated reasonable prognostic stratification for patients admitted to the internal medicine ward with SARS-CoV-2-induced pneumonia. The inclusion of Delirium and IL6 as additional prognostic indicators in the scoring systems enhanced their predictive performance, specifically in determining in-hospital mortality among COVID-19 patients.
Identifiants
pubmed: 37329431
doi: 10.1007/s11739-023-03336-2
pii: 10.1007/s11739-023-03336-2
pmc: PMC10504150
doi:
Substances chimiques
Interleukin-6
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1689-1700Informations de copyright
© 2023. The Author(s).
Références
Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. Lancet 395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
doi: 10.1016/S0140-6736(20)30183-5
pubmed: 31986264
pmcid: 7159299
Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
doi: 10.1016/S0140-6736(20)30211-7
pubmed: 32007143
pmcid: 7135076
Chandra A, Nicks B, Maniago E, Nouh A et al (2010) A multicenter analysis of the ED diagnosis of pneumonia. Am J Emerg Med 28:862–865. https://doi.org/10.1016/j.ajem.2009.04.014
doi: 10.1016/j.ajem.2009.04.014
pubmed: 20887906
Shah BA, Ahmed W, Dhobi GN, Shah NN, Khursheed SQ, Haq I (2010) Validity of pneumonia severity index and CURB-65 severity scoring systems in community acquired pneumonia in an Indian setting. Indian J Chest Dis Allied Sci 52(1):9–17
doi: 10.5005/ijcdas-52-1-9
pubmed: 20364609
Brabrand M, Henriksen DP (2018) CURB-65 score is equal to NEWS for identifying mortality risk of pneumonia patients: an observational study. Lung 196:359–361. https://doi.org/10.1007/s00408-018-0105-y
doi: 10.1007/s00408-018-0105-y
pubmed: 29541854
Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336(4):243–250. https://doi.org/10.1056/NEJM199701233360402
doi: 10.1056/NEJM199701233360402
pubmed: 8995086
Innocenti F, De Paris A, Lagomarsini A, Pelagatti L, Casalini L, Gianno A, Montuori M, Bernardini P, Caldi F, Tassinari I, Pini R (2022) Stratification of patients admitted for SARS-CoV2 infection: prognostic scores in the first and second wave of the pandemic. Intern Emerg Med 22:1–9. https://doi.org/10.1007/s11739-022-03016-7
doi: 10.1007/s11739-022-03016-7
Ji D, Zhang D, Xu J, Chen Z et al (2020) Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score. Clin Infect Dis 71:1393–1399. https://doi.org/10.1093/cid/ciaa414
doi: 10.1093/cid/ciaa414
pubmed: 32271369
Bartoletti M, Giannella M, Scudeller L, Tedeschi S, Rinaldi M, Bussini L, Fornaro G, Pascale R, Pancaldi L, Pasquini Z, Trapani F, Badia L, Campoli C, Tadolini M, Attard L, Puoti M, Merli M, Mussini C, Menozzi M, Meschiari M, Codeluppi M, Barchiesi F, Cristini F, Saracino A, Licci A, Rapuano S, Tonetti T, Gaibani P, Ranieri VM, Viale P, PREDICO Study Group (2020) Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study). Clin Microbiol Infect 26(11):1545–1553. https://doi.org/10.1016/j.cmi.2020.08.003
doi: 10.1016/j.cmi.2020.08.003
pubmed: 32781244
pmcid: 7414420
Fumagalli C, Ungar A, Rozzini R, Vannini M, Coccia F, Cesaroni G, Mazzeo F, D’Ettore N, Zocchi C, Tassetti L, Bartoloni A, Lavorini F, Marcucci R, Olivotto I, Rasero L, Fattirolli F, Fumagalli S, Marchionni N (2021) Predicting mortality risk in older hospitalized persons with COVID-19: a comparison of the COVID-19 mortality risk score with frailty and disability. J Am Med Dir Assoc 22(8):1588-1592.e1. https://doi.org/10.1016/j.jamda.2021.05.028
doi: 10.1016/j.jamda.2021.05.028
pubmed: 34334160
pmcid: 8249822
Grifoni E, Valoriani A, Cei F, Lamanna R, Gelli AMG, Ciambotti B, Vannucchi V, Moroni F, Pelagatti L, Tarquini R, Landini G, Vanni S, Masotti L (2020) Interleukin-6 asprognosticator in patients with COVID-19. J Infect 81(3):452–482. https://doi.org/10.1016/j.jinf.2020.06.008
doi: 10.1016/j.jinf.2020.06.008
pubmed: 32526326
pmcid: 7278637
Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS (2020) Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 7(7):611–627. https://doi.org/10.1016/S2215-0366(20)30203-0 . (Epub 2020 May 18)
doi: 10.1016/S2215-0366(20)30203-0
pubmed: 32437679
pmcid: 7234781
Forster P, Forster L, Renfrew C, Forster M (2020) Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci USA 117(17):9241–9243. https://doi.org/10.1073/pnas.2004999117
doi: 10.1073/pnas.2004999117
pubmed: 32269081
pmcid: 7196762
Grifoni E, Valoriani A, Cei F, Vannucchi V, Moroni F, Pelagatti L, Tarquini R, Landini G, Masotti L (2021) The CALL score for predicting outcomes in patients with COVID-19. Clin Infect Dis 72(1):182–183. https://doi.org/10.1093/cid/ciaa686
doi: 10.1093/cid/ciaa686
pubmed: 32474605
Martín-Jiménez P, Muñoz-García MI, Seoane D, Roca-Rodríguez L, García-Reyne A, Lalueza A, Maestro G, Folgueira D, Blanco-Palmero VA, Herrero-San Martín A, Llamas-Velasco S, Pérez-Martínez DA, González-Sánchez M, Villarejo-Galende A (2020) Cognitive impairment is a common comorbidity in deceased COVID-19 patients: a hospital-based retrospective cohort study. J Alzheimers Dis 78(4):1367–1372. https://doi.org/10.3233/JAD-200937
doi: 10.3233/JAD-200937
pubmed: 33074239
Hariyanto TI, Putri C, Arisa J, Situmeang RFV, Kurniawan A (2021) Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis. Arch Gerontol Geriatr 93:104299. https://doi.org/10.1016/j.archger.2020.104299
doi: 10.1016/j.archger.2020.104299
pubmed: 33285424
Gordon EM, Yao X, Xu H, Karkowsky W, Kaler M, Kalchiem-Dekel O, Barochia AV, Gao M, Keeran KJ, Jeffries KR, Levine SJ (2019) Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1β secretion by bronchoalveolar fluid macrophages from asthmatic subjects. J Allergy Clin Immunol 144(2):426-441.e3. https://doi.org/10.1016/j.jaci.2019.02.027
doi: 10.1016/j.jaci.2019.02.027
pubmed: 30872118
pmcid: 9152878
Goldstein MR, Poland GA, Graeber ACW (2020) Does apolipoprotein E genotype predict COVID-19 severity? QJM 113(8):529–530. https://doi.org/10.1093/qjmed/hcaa142
doi: 10.1093/qjmed/hcaa142
pubmed: 32339247
Rahman MA, Islam K, Rahman S, Alamin M (2021) Neurobiochemical cross-talk between COVID-19 and Alzheimer’s disease. Mol Neurobiol 58(3):1017–1023. https://doi.org/10.1007/s12035-020-02177-w . (Epub 2020 Oct 19)
doi: 10.1007/s12035-020-02177-w
pubmed: 33078369
Xiong N, Schiller MR, Li J, Chen X, Lin Z (2021) Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again? Alzheimers Res Ther 13(1):111. https://doi.org/10.1186/s13195-021-00858-9
doi: 10.1186/s13195-021-00858-9
pubmed: 34118974
pmcid: 8197596
Rodrigues JCG, Pinto P, Leitão LPC, Vinagre LWMS, Monte N, Fernandes MR, Khayat AS, de Assumpção PP, Santos NPCD, Santos SEBD (2021) Influence of APOE locus on poor prognosis of COVID-19. Heliyon. 7(6):e07379. https://doi.org/10.1016/j.heliyon.2021.e07379 . (Epub 2021 Jun 23)
doi: 10.1016/j.heliyon.2021.e07379
pubmed: 34179542
pmcid: 8220252
Zhu J, Pang J, Ji P et al (2021) Elevated interleukin-6 is associated with severity of COVID-19: a meta-analysis. J Med Virol 93(1):35–37
doi: 10.1002/jmv.26085
pubmed: 32470146
Shao SC, Lai CC, Chen YH et al (2021) Prevalence, incidence and mortality of delirium in patients with COVID-19: a systematic review and meta-analysis. Age Ageing 50(5):1445–1453
doi: 10.1093/ageing/afab103
pubmed: 33984129
Pranata R, Huang I, Lim MA et al (2021) Delirium and mortality in coronavirus disease 2019 (COVID-19)—a systematic review and meta-analysis. Arch Gerontol Geriatr 95:104388
doi: 10.1016/j.archger.2021.104388
pubmed: 33713880
pmcid: 7933794
Inouye SK, Westendorp RG, Saczynski JS (2014) Delirium in elderly people. Lancet (London, England). 383(9920):911–922
doi: 10.1016/S0140-6736(13)60688-1
pubmed: 23992774
Beach SR, Praschan NC, Hogan C et al (2020) Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement. Gen Hosp Psychiatry 65:47–53
doi: 10.1016/j.genhosppsych.2020.05.008
pubmed: 32470824
pmcid: 7242189
Cipriani G, Danti S, Nuti A et al (2020) A complication of coronavirus disease 2019: delirium. Acta Neurol Belg 120(4):927–932
doi: 10.1007/s13760-020-01401-7
pubmed: 32524537
pmcid: 7286634
Witlox J, Eurelings LS, de Jonghe JF et al (2010) Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA 304(4):443–451
doi: 10.1001/jama.2010.1013
pubmed: 20664045